LexDanaLexDanabeta
Inventor

WENGE ZHONG

Inventor
US

Overview

4→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry10%
PatentTitleYear
12,516,041Crystal forms of GLP-1R agonists and uses thereof202612,365,670GLP-IR agonists and uses thereof202512,285,429CDK inhibitors202511,591,321GLP-1R agonists and uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to QILU REGOR THERAPEUTICS INC (3)· patent assignee history
2023–2026Based in US· patent location history
2025Patents assigned to GENENTECH INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
QILU REGOR THERAPEUTICS INC32023–2026
GENENTECH INC12025
Locations
LocationPatentsSpan
US42023–2026